Comparing two PET scans for stomach cancer
Part of Cancer, Digestive system clinical trials.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with stomach cancer
- You can have both a FAPI PET/CT and an FDG PET/CT scan within a week
- You are willing to have blood tests for tumor markers before and after the scans
- You do not have any other active cancer or serious health problems like heart, kidney, or liver issues
- You do not have any condition that prevents you from having a PET scan, and your medical records are complete
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at two types of scans—18F-FAPI PET/CT and MRI—to see how they compare for people with suspected or diagnosed gastric cancer. The goal is to learn which scan gives better information to help guide care.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This trial uses two types of PET/CT scans (FDG and FAPI) to see how well chemotherapy or other treatments work before surgery for stomach cancer that has spread to the lining of the abdomen. The goal is to find the best way to measure treatment response and help guide your care.
This study compares two types of PET scans (FDG and FAPI) in people with suspected or newly diagnosed cancer. It aims to learn which scan gives better images of different cancers, potentially helping guide treatment decisions.
This study compares two types of PET/CT scans—one that uses FDG and one that uses FAPI—to help doctors see and evaluate cancer in different situations. It may help improve how well scans detect tumors and guide care, though it requires getting both scans scheduled.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.